Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 206430
Company: CUSTOPHARM INC
Company: CUSTOPHARM INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| VALRUBICIN | VALRUBICIN | 40MG/ML | SOLUTION;INTRAVESICAL | Prescription | AO | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/19/2019 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
VALRUBICIN
SOLUTION;INTRAVESICAL; 40MG/ML
TE Code = AO
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| VALRUBICIN | VALRUBICIN | 40MG/ML | SOLUTION;INTRAVESICAL | Prescription | No | AO | 206430 | CUSTOPHARM INC |
| VALSTAR PRESERVATIVE FREE | VALRUBICIN | 40MG/ML | SOLUTION;INTRAVESICAL | Prescription | Yes | AO | 020892 | ENDO PHARM |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English